Home › Funds › Prosight Management, LP › ZYME

Prosight Management, LP position in ZYME

ZYMEWORKS INC · Health Care

Prosight Management, LP reported holding 721,100 shares of ZYME (ZYMEWORKS INC) in its Q3 2026 13F filing — a position valued at US$19.1M, representing 3.71% of its reported portfolio and ranking #12 among its reported holdings. Prosight Management, LP has disclosed ZYME holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)721.10K sh
Reported value held$19.10M
Portfolio Weight3.71%
First reportedQ3 2023
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Prosight Management, LP's ZYME position evolved

Prosight Management, LP first disclosed a stake in ZYME in Q3 2023 at 106,405 shares (US$675K). The position peaked in Q3 2026 at 721,100 shares, worth US$19.1M. Across 12 filings, Prosight Management, LP increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 721,100 shares valued at US$19.1M — an increase of 46,666 shares quarter over quarter.. Notable position changes include a 187% increase in Q2 2024 (shares rose 47% over the following quarter), a 37% increase in Q2 2025 (shares rose 36% over the following quarter), a 43% trim in Q3 2025 (shares rose 54% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 106.41K $674.61K New
Q1 2024 410.95K $4.32M New
Q2 2024 1.18M $10.04M Add
Q3 2024 917.60K $11.52M Reduce
Q4 2024 820.00K $12.00M Reduce
Q1 2025 957.23K $11.40M Add
Q2 2025 1.31M $16.44M Add
Q3 2025 749.61K $12.80M Reduce
Q4 2025 530.39K $13.97M Reduce
Q1 2026 539.05K $13.50M Add
Q2 2026 674.43K $17.63M Add
Q3 2026 721.10K $19.10M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZYME and 13F data

ZYME (ZYMEWORKS INC) is a Health Care company. 25 other funds we track also report a position in ZYME — the largest reported positions include EcoR1 Capital, LLC (US$600.4M), Rubric Capital Management LP (US$183.0M), PERCEPTIVE ADVISORS LLC (US$109.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZYME

All ZYME fund holders →

FAQ

How long has Prosight Management, LP held ZYME?

Prosight Management, LP has disclosed ZYME holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is Prosight Management, LP's current position in ZYME?

As of Q3 2026, Prosight Management, LP holds 721.10K shares of ZYME (ZYMEWORKS INC), valued at $19.10M, representing 3.71% of its reported portfolio and ranking #12.

Has Prosight Management, LP been buying or selling ZYME?

In the latest 13F filing (Q3 2026), Prosight Management, LP increased its position in ZYME. The position peaked in Q3 2026 at 721.10K shares.

Which other funds hold ZYME?

Other major institutional holders of ZYME include EcoR1 Capital, LLC, Rubric Capital Management LP, PERCEPTIVE ADVISORS LLC, among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.